{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:30:37Z","timestamp":1790965837925,"version":"4.1.0"},"reference-count":205,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["IAD"],"published-print":{"date-parts":[[2021,1,15]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Alopecia Areata (AA) is a systemic autoimmune condition that usually starts in childhood.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective:<\/jats:title><jats:p>This article aims to review genetics, therapy, prognosis, and recent patents for AA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>We used clinical queries and keywords \u201calopecia areata\u201d AND \u201cchildhood\u201d as a search engine. Patents were searched using the key term \u201calopecia areata\u201d in Patents.google.com and freepatentsonline. com.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Due to an immune-mediated damage to the hair follicles, hair is lost from the scalp and other areas of the body temporarily or even permanently. Children with AA are generally healthy. Evidence of genetic association and increased predisposition for AA was found by studying families with affected members. Pathophysiologically, T- lymphocytes attack hair follicles and cause inflammation and destruction of the hair follicles and hair loss. In mild cases, there would be well-demarcated round patchy scalp hair loss. The pathognomonic \u201cexclamation mark hairs\u201d may be seen at the lesion periphery. In more severe cases, the hair loss may affect the whole scalp and even the whole body. The clinical course is also variable, which may range from transient episodes of recurrent patchy hair loss to an indolent gradually deteriorating severe hair loss. The treatment of AA depends on factors including patients\u2019 age, the extent of the hair loss, duration of disease, psychological impact, availability and side effect profile of the treatments. For localized patchy alopecia, topical application of corticosteroids and\/or intralesional corticosteroids are the treatment of choice. Other topical treatments include minoxidil, anthralin, coal tar and immunotherapy. In severe resistant cases, systemic immunosuppressants may be considered. Although herbal medicine, acupuncture, complementary and alternative medicine may be tried on children in some Asian communities, the evidence to support these practices is lacking. To date, only a few recent patents exist in topical treatments, including Il-31, laser and herbal medications. Clinical efficacy is pending for these treatment modalities.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>None of the established therapeutic options are curative. However, newer treatment modalities, including excimer laser, interleukin-31 antibodies and biologics, are evolving so that there may be significant advances in treatment in the near future. AA can be psychosocially devastating. It is important to assess the quality of life, degree of anxiety, social phobia and mood of the patients and their families. Psychological support is imperative for those who are adversely affected psychosocially.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1872213x14999200728145822","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T06:37:47Z","timestamp":1596004667000},"page":"117-132","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Childhood Alopecia Areata: An Overview of Treatment and Recent Patents"],"prefix":"10.2174","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6682-5529","authenticated-orcid":true,"given":"Kam L.","family":"Hon","sequence":"first","affiliation":[{"name":"Department of Paediatrics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7854-0221","authenticated-orcid":true,"given":"David C.K.","family":"Luk","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine, United Christian Hospital, Kwun Tong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2254-6971","authenticated-orcid":true,"given":"Alexander K.C.","family":"Leung","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The University of Calgary and The Alberta Children\u2019s Hospital, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9037-5994","authenticated-orcid":true,"given":"Chantel","family":"Ng","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5142-0297","authenticated-orcid":true,"given":"Steven K.F.","family":"Loo","sequence":"additional","affiliation":[{"name":"Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S0190-9622(84)80450-8","volume":"11","author":"Mitchell A.J.","year":"1984","unstructured":"Mitchell A.J.; Krull E.A.; Alopecia areata: Pathogenesis and treatment. J Am Acad Dermatol 1984,11(5 Pt 1),763-775","journal-title":"J Am Acad Dermatol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2174\/187221311795399291","volume":"5","author":"Hon K.L.","year":"2011","unstructured":"Hon K.L.; Leung A.K.; Alopecia areata. Recent Pat Inflamm Allergy Drug Discov 2011,5(2),98-107","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s12325-008-0044-8","volume":"25","author":"Hon K-L.","year":"2008","unstructured":"Hon K-L.; Leung A.K.; Ng P.C.; Unusual loss of body hair in childhood: Trichotillomania or alopecia. Adv Ther 2008,25(4),380-387","journal-title":"Adv Ther"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.it.2004.09.014","volume":"26","author":"Paus R.","year":"2005","unstructured":"Paus R.; Nickoloff B.J.; Ito T.; A \u2018hairy\u2019 privilege. Trends Immunol 2005,26(1),32-40","journal-title":"Trends Immunol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1177\/146642409311300509","volume":"113","author":"Leung A.K.","year":"1993","unstructured":"Leung A.K.; Robson W.L.; Hair loss in children. J R Soc Health 1993,113(5),252-256","journal-title":"J R Soc Health"},{"key":"ref=6","first-page":"CD004413","author":"Delamere F.M.","year":"2008","unstructured":"Delamere F.M.; Sladden M.M.; Dobbins H.M.; Leonardi-Bee J.; Interventions for alopecia areata. Cochrane Database Syst Rev 2008(2),CD004413","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jaad.2019.08.032","volume":"82","author":"Lee H.H.","year":"2020","unstructured":"Lee H.H.; Gwillim E.; Patel K.R.; Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis. J Am Acad Dermatol 2020,82(3),675-82","journal-title":"J Am Acad Dermatol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"628","DOI":"10.4065\/70.7.628","volume":"70","author":"Safavi K.H.","year":"1995","unstructured":"Safavi K.H.; Muller S.A.; Suman V.J.; Moshell A.N.; Melton L.J.; Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc 1995,70(7),628-633","journal-title":"Mayo Clin Proc"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.autrev.2005.07.001","volume":"5","author":"Gilhar A.","year":"2006","unstructured":"Gilhar A.; Kalish R.S.; Alopecia areata: A tissue specific autoimmune disease of the hair follicle. Autoimmun Rev 2006,5(1),64-69","journal-title":"Autoimmun Rev"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jaad.2009.10.032","volume":"62","author":"Alkhalifah A.","year":"2010","unstructured":"Alkhalifah A.; Alsantali A.; Wang E.; McElwee K.J.; Shapiro J.; Alopecia areata update: Part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol 2010,62(2),177-188","journal-title":"J Am Acad Dermatol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.0736-8046.2004.21203.x","volume":"21","author":"Hon K.L.","year":"2004","unstructured":"Hon K.L.; Leung T.F.; Wong Y.; Ma K.C.; Fok T.F.; Skin diseases in Chinese children at a pediatric dermatology center. Pediatr Dermatol 2004,21(2),109-112","journal-title":"Pediatr Dermatol"},{"key":"ref=12","first-page":"104","volume":"82","author":"Hawit F.","year":"2008","unstructured":"Hawit F.; Silverberg N.B.; Alopecia areata in children. Cutis 2008,82(2),104-110","journal-title":"Cutis"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1046\/j.1525-1470.1999.99002.x","volume":"16","author":"Nanda A.","year":"1999","unstructured":"Nanda A.; Al-Hasawi F.; Alsaleh Q.A.; A prospective survey of pediatric dermatology clinic patients in Kuwait: An analysis of 10,000 cases. Pediatr Dermatol 1999,16(1),6-11","journal-title":"Pediatr Dermatol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1471-5945-5-11","volume":"5","author":"Seyrafi H.","year":"2005","unstructured":"Seyrafi H.; Akhiani M.; Abbasi H.; Mirpour S.; Gholamrezanezhad A.; Evaluation of the profile of alopecia areata and the prevalence of thyroid function test abnormalities and serum autoantibodies in Iranian patients. BMC Dermatol 2005,5,11","journal-title":"BMC Dermatol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.sder.2008.12.002","volume":"28","author":"Garg S.","year":"2009","unstructured":"Garg S.; Messenger A.G.; Alopecia areata: Evidence-based treatments. Semin Cutan Med Surg 2009,28(1),15-18","journal-title":"Semin Cutan Med Surg"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"68S","DOI":"10.1111\/1523-1747.ep12471869","volume":"96","author":"Price V.H.","year":"1991","unstructured":"Price V.H.; Alopecia areata: Clinical aspects. J Invest Dermatol 1991,96(5),68S","journal-title":"J Invest Dermatol"},{"key":"ref=17","first-page":"397","volume":"8","author":"Villasante Fricke A.C.","year":"2015","unstructured":"Villasante Fricke A.C.; Miteva M.; Villasante A.; Villasante Fricke A.C.; Miteva M.; Epidemiology and burden of alopecia areata: A systematic review. Clin Cosmet Investig Dermatol 2015,8,397-403","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref=18","doi-asserted-by":"crossref","unstructured":"Villasante Fricke AC, Miteva M. Epidemiology and burden of alopecia areata: A systematic review. Clin Cosmet Investig Dermatol 2015; 8: 397-403.","DOI":"10.2147\/CCID.S53985"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1001\/archderm.1963.01590210048007","volume":"88","year":"1963","unstructured":"Muller SA, Winkelmann RK. Alopecia areata. An evaluation of 736 patients. Arch Dermatol 1963,88,290-7","journal-title":"Arch Dermatol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1365-4362.1992.tb03932.x","volume":"31","author":"Shellow W.V.","year":"1992","unstructured":"Shellow W.V.; Edwards J.E.; Koo J.Y.; Profile of alopecia areata: A questionnaire analysis of patient and family. Int J Dermatol 1992,31(3),186-189","journal-title":"Int J Dermatol"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2340\/0001555572373375","volume":"72","author":"van der Steen P.","year":"1992","unstructured":"van der Steen P.; Traupe H.; Happle R.; Boezeman J.; Str\u00e4ter R.; Hamm H.; The genetic risk for alopecia areata in first degree relatives of severely affected patients. An estimate. Acta Derm Venereol 1992,72(5),373-375","journal-title":"Acta Derm Venereol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1086\/511442","volume":"80","author":"Martinez-Mir A.","year":"2007","unstructured":"Martinez-Mir A.; Zlotogorski A.; Gordon D.; Petukhova L.; Mo J.; Gilliam T.C.; Londono D.; Haynes C.; Ott J.; Hordinsky M.; Nanova K.; Norris D.; Price V.; Duvic M.; Christiano A.M.; Genomewide scan for linkage reveals evidence of several susceptibility loci for alopecia areata. Am J Hum Genet 2007,80(2),316-328","journal-title":"Am J Hum Genet"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3928\/00904481-20090511-07","volume":"38","author":"Mukherjee N.","year":"2009","unstructured":"Mukherjee N.; Burkhart C.N.; Morrell D.S.; Treatment of alopecia areata in children. Pediatr Ann 2009,38(7),388-395","journal-title":"Pediatr Ann"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jaad.2009.10.031","volume":"62","author":"Alkhalifah A.","year":"2010","unstructured":"Alkhalifah A.; Alsantali A.; Wang E.; McElwee K.J.; Shapiro J.; Alopecia areata update: Part II. Treatment. J Am Acad Dermatol 2010,62(2),191-202","journal-title":"J Am Acad Dermatol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1046\/j.1365-4362.2002.01357.x","volume":"41","author":"Tan E.","year":"2002","unstructured":"Tan E.; Tay Y.K.; Goh C.L.; Chin Giam Y.; The pattern and profile of alopecia areata in Singapore- a study of 219 Asians. Int J Dermatol 2002,41(11),748-753","journal-title":"Int J Dermatol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s12519-019-00230-w","volume":"15","author":"Leung A.K.C.","year":"2019","unstructured":"Leung A.K.C.; Leung A.A.C.; Evaluation and management of the child with hypothyroidism. World J Pediatr 2019,15(2),124-34","journal-title":"World J Pediatr"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2174\/1872213X113079990022","volume":"7","author":"Leung A.K.C.K.","year":"2013","unstructured":"Leung A.K.C.K.; Hon K-L.E.L.; Seasonal allergic rhinitis. Recent Pat Inflamm Allergy Drug Discov 2013,7(3),187-201","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.jaad.2018.06.029","volume":"79","author":"Putterman E.","year":"2018","unstructured":"Putterman E.; Castelo-Soccio L.; Seasonal patterns in alopecia areata, totalis, and universalis. J Am Acad Dermatol 2018,79(5),974-5","journal-title":"J Am Acad Dermatol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S146239940601101X","volume":"8","author":"Lu W.","year":"2006","unstructured":"Lu W.; Shapiro J.; Yu M.; Barekatain A.; Lo B.; Finner A.; McElwee K.; Alopecia areata: Pathogenesis and potential for therapy. Expert Rev Mol Med 2006,8(14),1-19","journal-title":"Expert Rev Mol Med"},{"key":"ref=30","doi-asserted-by":"crossref","unstructured":"Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Invest 2007; 117: 2019-7.","DOI":"10.1172\/JCI31942"},{"key":"ref=31","first-page":"188","volume":"2","author":"Paus R.","year":"2003","unstructured":"Paus R.; Ito N.; Takigawa M.; Ito T.; The hair follicle and immune privilege. J Investig Dermatology 2003,2,188-94","journal-title":"J Investig Dermatology"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S0002-9440(10)63151-3","volume":"164","author":"Ito T.","year":"2004","unstructured":"Ito T.; Ito N.; Bettermann A.; Tokura Y.; Takigawa M.; Paus R.; Collapse and restoration of MHC class-I-dependent immune privilege: Exploiting the human hair follicle as a model. Am J Pathol 2004,164(2),623-634","journal-title":"Am J Pathol"},{"key":"ref=33","first-page":"541","volume":"66","author":"Paus R.","year":"1993","unstructured":"Paus R.; Slominski A.; Czarnetzki B.M.; Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? Yale J Biol Med 1993,66(6),541-554","journal-title":"Yale J Biol Med"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1016\/S0140-6736(01)06943-4","volume":"358","author":"Randall V.A.","year":"2001","unstructured":"Randall V.A.; Is alopecia areata an autoimmune disease?. Lancet 2001,358(9297),1922-1924","journal-title":"Lancet"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1600-0625.1999.tb00385.x","volume":"8","author":"McElwee K.J.","year":"1999","unstructured":"McElwee K.J.; Tobin D.J.; Bystryn J.C.; King L.E.; Sundberg J.P.; Alopecia areata: An autoimmune disease?. Exp Dermatol 1999,8(5),371-379","journal-title":"Exp Dermatol"},{"key":"ref=36","first-page":"164","volume":"2","author":"Kalish R.S.","year":"2003","unstructured":"Kalish R.S.; Gilhar A.; Alopecia areata: Autoimmunity-the evidence is compelling. J Investig Dermatology 2003,2,164-7","journal-title":"J Investig Dermatology"},{"key":"ref=37","first-page":"87","volume":"1","year":"2003","unstructured":"Tang L, Cao L, Pelech S, Lui H, Shapiro J. Cytokines and signal transduction pathways mediated by anthralin in alopecia areata-affected Dundee experimental balding rats. J Investig Dermatol Symp Proc 2003,1,87-90","journal-title":"J Investig Dermatol Symp Proc"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/DAD.0b013e318185a66e","volume":"31","author":"Cetin E.D.","year":"2009","unstructured":"Cetin E.D.; Savk E.; Uslu M.; Eskin M.; Karul A.; Investigation of the inflammatory mechanisms in alopecia areata. Am J Dermatopathol 2009,31(1),53-60","journal-title":"Am J Dermatopathol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"28S","DOI":"10.1038\/jid.1995.48","volume":"104","author":"Hordinsky M.K.","year":"1995","unstructured":"Hordinsky M.K.; Kennedy W.; Wendelschafer-Crabb G.; Lewis S.; Structure and function of cutaneous nerves in alopecia areata. J Invest Dermatol 1995,104(5)(Suppl.),28S-29S","journal-title":"J Invest Dermatol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/jid.2009.111","volume":"129","author":"Paus R.","year":"2009","unstructured":"Paus R.; Arck P.; Neuroendocrine perspectives in alopecia areata: Does stress play a role? J Invest Dermatol 2009,129(6),1324-1326","journal-title":"J Invest Dermatol"},{"key":"ref=41","first-page":"277","volume":"143","author":"Grandolfo M.","year":"2008","unstructured":"Grandolfo M.; Biscazzi A.M.; Pipoli M.; Alopecia areata and autoimmunity. G Ital Dermatol Venereol 2008,143(5),277-281","journal-title":"G Ital Dermatol Venereol"},{"key":"ref=42","first-page":"73","volume":"1","author":"Hordinsky M.","year":"2004","unstructured":"Hordinsky M.; Ericson M.; Autoimmunity: Alopecia areata. J Investig Dermatology 2004,1,73-8","journal-title":"J Investig Dermatology"},{"key":"ref=43","first-page":"5","volume":"39","author":"Lutz G.","year":"1988","unstructured":"Lutz G.; Bauer R.; Autoimmunity in alopecia areata. An assessment in 100 patients. Hautarzt 1988,39(1),5-11","journal-title":"Hautarzt"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1111\/j.1365-2133.1969.tb15967.x","volume":"81","author":"Cunliffe W.J.","year":"1969","unstructured":"Cunliffe W.J.; Hall R.; Stevenson C.J.; Weightman D.; Alopecia areata, thyroid disease and autoimmunity. Br J Dermatol 1969,81(12),877-881","journal-title":"Br J Dermatol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/nm.3645","volume":"20","author":"Xing L.","year":"2014","unstructured":"Xing L.; Dai Z.; Jabbari A.; Cerise J.E.; Higgins C.A.; Gong W.; de Jong A.; Harel S.; DeStefano G.M.; Rothman L.; Singh P.; Petukhova L.; Mackay-Wiggan J.; Christiano A.M.; Clynes R.; Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition. Nat Med 2014,20(9),1043-1049","journal-title":"Nat Med"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1046\/j.1468-3083.2000.00097-14.x","volume":"14","author":"Verma D.D.","year":"2004","unstructured":"Verma D.D.; Verma S.; McElwee K.J.; Freyschmidt-Paul P.; Hoffman R.; Fahr A.; Treatment of alopecia areata in the DEBR model using Cyclosporin A lipid vesicles. Eur J Dermatol 2004,14(5),332-338","journal-title":"Eur J Dermatol"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jaad.2005.12.007","volume":"54","author":"Blaumeiser B.","year":"2006","unstructured":"Blaumeiser B.; van der Goot I.; Fimmers R.; Familial aggregation of alopecia areata. J Am Acad Dermatol 2006,54(4),627-32","journal-title":"J Am Acad Dermatol"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jdermsci.2016.10.004","volume":"86","author":"Dainichi T.","year":"2017","unstructured":"Dainichi T.; Kabashima K.; Alopecia areata: What\u2019s new in epidemiology, pathogenesis, diagnosis, and therapeutic options?. J Dermatol Sci 2017,86(1),3-12","journal-title":"J Dermatol Sci"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jaad.2009.02.006","volume":"62","author":"Rodriguez T.A.","year":"2010","unstructured":"Rodriguez T.A.; Fernandes K.E.; Dresser K.L.; Duvic M.; Concordance rate of alopecia areata in identical twins supports both genetic and environmental factors. J Am Acad Dermatol National Alopecia Areata Registry2010,62(3),525-527","journal-title":"J Am Acad Dermatol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0190-9622(08)80226-5","volume":"27","author":"Scerri L.","year":"1992","unstructured":"Scerri L.; Pace J.L.; Identical twins with identical alopecia areata. J Am Acad Dermatol 1992,27(5 Pt 1),766-767","journal-title":"J Am Acad Dermatol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1742-4801.2004.00054.x","volume":"1","author":"Carter P.S.","year":"2004","unstructured":"Carter P.S.; Banwell P.E.; Necrotising fasciitis: A new management algorithm based on clinical classification. Int Wound J 2004,1(3),189-198","journal-title":"Int Wound J"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1136\/bmj.1.5951.191","volume":"1","author":"Du Vivier A.","year":"1975","unstructured":"Du Vivier A.; Munro D.D.; Alopecia areata, autoimmunity, and Down\u2019s syndrome. BMJ 1975,1(5951),191-192","journal-title":"BMJ"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1365-2133.1981.tb01200.x","volume":"105","author":"Friedmann P.S.","year":"1981","unstructured":"Friedmann P.S.; Alopecia areata and auto-immunity. Br J Dermatol 1981,105(2),153-157","journal-title":"Br J Dermatol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature09114","volume":"466","author":"Petukhova L.","year":"2010","unstructured":"Petukhova L.; Duvic M.; Hordinsky M.; Norris D.; Price V.; Shimomura Y.; Kim H.; Singh P.; Lee A.; Chen W.V.; Meyer K.C.; Paus R.; Jahoda C.A.; Amos C.I.; Gregersen P.K.; Christiano A.M.; Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature 2010,466(7302),113-117","journal-title":"Nature"},{"key":"ref=55","first-page":"757","volume":"33","author":"Colombe B.W.","year":"1995","unstructured":"Colombe B.W.; Price V.H.; Khoury E.L.; Garovoy M.R.; Lou C.D.; HLA class II antigen associations help to define two types of alopecia areata. J Am Acad Dermatol 1995,33(5 Pt 1),757-764","journal-title":"J Am Acad Dermatol"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/sj.jidsp.5640214","volume":"4","year":"1999","unstructured":"Colombe BW, Lou CD, Price VH. The genetic basis of alopecia areata: HLA associations with patchy alopecia areata versus alopecia totalis and alopecia universalis. J Investig Dermato Symp Proc 1999,4(3),216-9","journal-title":"J Investig Dermato Symp Proc"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/1523-1747.ep12412584","volume":"103","author":"Welsh E.A.","year":"1994","unstructured":"Welsh E.A.; Clark H.H.; Epstein S.Z.; Reveille J.D.; Duvic M.; Human leukocyte antigen-DQB1*03 alleles are associated with alopecia areata. J Invest Dermatol 1994,103(6),758-763","journal-title":"J Invest Dermatol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/j.1365-2133.2011.10466.x","volume":"165","author":"Megiorni F.","year":"2011","unstructured":"Megiorni F.; Pizzuti A.; Mora B.; Rizzuti A.; Garelli V.; Maxia C.; Carlesimo M.; Fotruna M.C.; Delle Chiaie R.; Cavaggioni G.; Rossi A.; Genetic association of HLA-DQB1 and HLA-DRB1 polymorphisms with alopecia areata in the Italian population. Br J Dermatol 2011,165(4),823-827","journal-title":"Br J Dermatol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S0733-8635(05)70394-6","volume":"14","author":"Price V.H.","year":"1996","unstructured":"Price V.H.; Colombe B.W.; Heritable factors distinguish two types of alopecia areata. Dermatol Clin 1996,14(4),679-689","journal-title":"Dermatol Clin"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jdermsci.2015.01.004","volume":"78","year":"2015","unstructured":"Biran R, Zlotogorski A, Ramot Y. The genetics of alopecia areata: New approaches, new findings, new treatments. J Dermatol Sci 2015,78,11-20","journal-title":"J Dermatol Sci"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1529-8019.2011.01411.x","volume":"24","author":"Petukhova L.","year":"2011","unstructured":"Petukhova L.; Cabral R.M.; Mackay-Wiggan J.; Clynes R.; Christiano A.M.; The genetics of alopecia areata: What\u2019s new and how will it help our patients? Dermatol Ther (Heidelb) 2011,24(3),326-336","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref=62","first-page":"30890","volume":"S0190-9622","year":"2019","unstructured":"Okhovat J-P, Marks DH, Manatis-Lornell A, Hagigeorges D, Locascio JJ, Senna MM. Association between alopecia areata, anxiety, and depression: A systematic review and meta-analysis. J Am Acad Dermatol 2019,S0190-9622(19),30890-4","journal-title":"J Am Acad Dermatol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/ced.12556","volume":"40","author":"Yenin J.Z.","year":"2015","unstructured":"Yenin J.Z.; Serarslan G.; Y\u00f6nden Z.; Uluta\u015f K.T.; Investigation of oxidative stress in patients with alopecia areata and its relationship with disease severity, duration, recurrence and pattern. Clin Exp Dermatol 2015,40(6),617-21","journal-title":"Clin Exp Dermatol"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/jdv.15885","volume":"34","author":"Moreno-Arrones O.M.","year":"2020","unstructured":"Moreno-Arrones O.M.; Serrano-Villar S.; Perez-Brocal V.; Analysis of the gut microbiota in alopecia areata: Identification of bacterial biomarkers. J Eur Acad Dermatol Venereol 2020,34(2),400-5","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1067\/mjd.2000.103909","volume":"42","author":"Madani S.","year":"2000","unstructured":"Madani S.; Shapiro J.; Alopecia areata update. J Am Acad Dermatol 2000,42(4),549-566","journal-title":"J Am Acad Dermatol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1159\/000287786","volume":"41","author":"Perini G.I.","year":"1984","unstructured":"Perini G.I.; Veller Fornasa C.; Cipriani R.; Bettin A.; Zecchino F.; Peserico A.; Life events and alopecia areata. Psychother Psychosom 1984,41(1),48-52","journal-title":"Psychother Psychosom"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S1578-2190(10)70667-3","volume":"101","author":"Morales-S\u00e1nchez M.A.","year":"2010","unstructured":"Morales-S\u00e1nchez M.A.; Dom\u00ednguez-G\u00f3mez M.A.; Jurado-Santa Cruz F.; Peralta-Pedrero M.L.; Immunization and bacterial pathogens in the oropharynx as risk factors for alopecia areata. Actas Dermosifiliogr 2010,101(5),437-443","journal-title":"Actas Dermosifiliogr"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jaad.2006.05.008","volume":"55","author":"Tosti A.","year":"2006","unstructured":"Tosti A.; Bellavista S.; Iorizzo M.; Alopecia areata: A long term follow-up study of 191 patients. J Am Acad Dermatol 2006,55(3),438-441","journal-title":"J Am Acad Dermatol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1365-4362.1996.tb01610.x","volume":"35","author":"Sharma V.K.","year":"1996","unstructured":"Sharma V.K.; Dawn G.; Kumar B.; Profile of alopecia areata in Northern India. Int J Dermatol 1996,35(1),22-27","journal-title":"Int J Dermatol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1046\/j.1365-4362.1999.00004.x","volume":"38","author":"Shapiro J.","year":"1999","unstructured":"Shapiro J.; Madani S.; Alopecia areata: Diagnosis and management. Int J Dermatol 1999,38(Suppl. 1),19-24","journal-title":"Int J Dermatol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s13555-020-00370-2","volume":"10","author":"Nowaczyk J.","year":"2020","unstructured":"Nowaczyk J.; Makowska K.; Rakowska A.; Sikora M.; Rudnicka L.; Cyclosporine with and without systemic corticosteroids in treatment of alopecia areata: A systematic review. Dermatol Ther (Heidelb) 2020,10(3),387-399","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2017.04.1141","volume":"78","author":"Strazzulla L.C.","year":"2018","unstructured":"Strazzulla L.C.; Wang E.H.C.; Avila L.; Alopecia areata: Disease characteristics, clinical evaluation, and new perspectives on pathogenesis. J Am Acad Dermatol 2018,78(1),1-12","journal-title":"J Am Acad Dermatol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1001\/jamadermatol.2013.3049","volume":"149","year":"2013","unstructured":"Huang KP, Mullangi S, Guo Y, Qureshi AA. Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States. JAMA Dermatol 2013,149(7),789-94","journal-title":"JAMA Dermatol"},{"key":"ref=74","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jaad.2009.04.031","volume":"61","author":"Barahmani N.","year":"2009","unstructured":"Barahmani N.; Schabath M.B.; Duvic M.; History of atopy or autoimmunity increases risk of alopecia areata. J Am Acad Dermatol 2009,61(4),581-91","journal-title":"J Am Acad Dermatol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/j.1468-3083.2006.02106.x","volume":"21","author":"Manolache L.","year":"2007","unstructured":"Manolache L.; Benea V.; Stress in patients with alopecia areata and vitiligo. J Eur Acad Dermatol Venereol 2007,21(7),921-928","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1365-4362.1994.tb02921.x","volume":"33","author":"Puavilai S.","year":"1994","unstructured":"Puavilai S.; Puavilai G.; Charuwichitratana S.; Sakuntabhai A.; Sriprachya-Anunt S.; Prevalence of thyroid diseases in patients with alopecia areata. Int J Dermatol 1994,33(9),632-633","journal-title":"Int J Dermatol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1001\/archderm.1992.01680130082010","volume":"128","author":"Werth V.P.","year":"1992","unstructured":"Werth V.P.; White W.L.; Sanchez M.R.; Franks A.G.; Incidence of alopecia areata in lupus erythematosus. Arch Dermatol 1992,128(3),368-371","journal-title":"Arch Dermatol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"5966","DOI":"10.1038\/ncomms6966","volume":"6","author":"Betz R.C.","year":"2015","unstructured":"Betz R.C.; Petukhova L.; Ripke S.; Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci. Nat Commun 2015,6,5966","journal-title":"Nat Commun"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1097\/00004583-199705000-00019","volume":"36","author":"Liakopoulou M.","year":"1997","unstructured":"Liakopoulou M.; Alifieraki T.; Katideniou A.; Kakourou T.; Tselalidou E.; Tsiantis J.; Stratigos J.; Children with alopecia areata: Psychiatric symptomatology and life events. J Am Acad Child Adolesc Psychiatry 1997,36(5),678-684","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2340\/0001555572279280","volume":"72","author":"van der Steen P.","year":"1992","unstructured":"van der Steen P.; Boezeman J.; Duller P.; Happle R.; Can alopecia areata be triggered by emotional stress? An uncontrolled evaluation of 178 patients with extensive hair loss. Acta Derm Venereol van der SP1992,72(4),279-280","journal-title":"Acta Derm Venereol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0010-440X(91)90045-E","volume":"32","author":"Col\u00f3n E.A.","year":"1991","unstructured":"Col\u00f3n E.A.; Popkin M.K.; Callies A.L.; Dessert N.J.; Hordinsky M.K.; Lifetime prevalence of psychiatric disorders in patients with alopecia areata. Compr Psychiatry 1991,32(3),245-251","journal-title":"Compr Psychiatry"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/0016-5085(95)90597-9","volume":"109","author":"Corazza G.R.","year":"1995","unstructured":"Corazza G.R.; Andreani M.L.; Venturo N.; Bernardi M.; Tosti A.; Gasbarrini G.; Celiac disease and alopecia areata: Report of a new association. Gastroenterology 1995,109(4),1333-1337","journal-title":"Gastroenterology"},{"key":"ref=83","first-page":"168","volume":"143","author":"Zampetti M.","year":"2008","unstructured":"Zampetti M.; Filippetti R.; Alopecia areata and celiac disease. G Ital Dermatol Venereol 2008,143(2),168","journal-title":"G Ital Dermatol Venereol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1046\/j.1440-1754.2003.00116.x","volume":"39","author":"Fessatou S.","year":"2003","unstructured":"Fessatou S.; Kostaki M.; Karpathios T.; Coeliac disease and alopecia areata in childhood. J Paediatr Child Health 2003,39(2),152-154","journal-title":"J Paediatr Child Health"},{"key":"ref=85","first-page":"169","volume":"120","author":"Tosti A.","year":"1985","unstructured":"Tosti A.; De Padova M.P.; Caponeri G.M.; Liverani L.; Gargano N.; Veronesi S.; Nail changes and alopecia areata. G Ital Dermatol Venereol 1985,120(3),169-171","journal-title":"G Ital Dermatol Venereol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1468-3083.1998.tb00727.x","volume":"10","author":"Sharma V.K.","year":"1998","unstructured":"Sharma V.K.; Dawn G.; Muralidhar S.; Kumar B.; Nail changes in 1000 Indian patients with alopecia areata. J Eur Acad Dermatol Venereol 1998,10(2),189-191","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1468-3083.2008.02830.x","volume":"23","author":"Kasumagic-Halilovic E.","year":"2009","unstructured":"Kasumagic-Halilovic E.; Prohic A.; Nail changes in alopecia areata: Frequency and clinical presentation. J Eur Acad Dermatol Venereol 2009,23(2),240-241","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=88","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jpeds.2019.08.034","volume":"216","author":"Leung A.K.C.","year":"2020","unstructured":"Leung A.K.C.; Leong K.F.; Barankin B.; Trachyonychia. J Pediatr 2020,216,239-239","journal-title":"J Pediatr"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/j.1365-4632.2008.03692.x","volume":"47","author":"Inui S.","year":"2008","unstructured":"Inui S.; Nakajima T.; Nakagawa K.; Itami S.; Clinical significance of dermoscopy in alopecia areata: Analysis of 300 cases. Int J Dermatol 2008,47(7),688-693","journal-title":"Int J Dermatol"},{"key":"ref=90","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jaad.2012.02.013","volume":"67","author":"Miteva M.","year":"2012","unstructured":"Miteva M.; Tosti A.; Hair and scalp dermatoscopy. J Am Acad Dermatol 2012,67(5),1040-8","journal-title":"J Am Acad Dermatol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.sder.2006.01.003","volume":"25","author":"Han A.","year":"2006","unstructured":"Han A.; Mirmirani P.; Clinical approach to the patient with alopecia. Semin Cutan Med Surg 2006,25(1),11-23","journal-title":"Semin Cutan Med Surg"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/j.jaad.2006.12.032","volume":"57","author":"Tokura Y.","year":"2007","unstructured":"Tokura Y.; Sugita K.; Kabashima K.; Ito T.; Yagi H.; Alopecia universalis associated with impaired interleukin-4 production and low serum IgE level. J Am Acad Dermatol 2007,57(2),S22-S25","journal-title":"J Am Acad Dermatol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/BF01061629","volume":"240","author":"Goos M.","year":"1971","unstructured":"Goos M.; The histopathology of alopecia areata. With special reference to the duration, location and progession of hair loss. Arch Dermatol Forsch 1971,240(2),160-172","journal-title":"Arch Dermatol Forsch"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"26S","DOI":"10.1038\/jid.1995.46","volume":"104","author":"Whiting D.A.","year":"1995","unstructured":"Whiting D.A.; Histopathology of alopecia areata in horizontal sections of scalp biopsies. J Invest Dermatol 1995,104(5),26S-27S","journal-title":"J Invest Dermatol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1046\/j.1524-4725.1999.99045.x","volume":"25","author":"Madani S.","year":"1999","unstructured":"Madani S.; Shapiro J.; The scalp biopsy: Making it more efficient. Dermatol Surg 1999,25(7),537-538","journal-title":"Dermatol Surg"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1001\/archderm.139.12.1555","volume":"139","author":"Whiting D.A.","year":"2003","unstructured":"Whiting D.A.; Histopathologic features of alopecia areata: A new look. Arch Dermatol 2003,139(12),1555-9","journal-title":"Arch Dermatol"},{"key":"ref=97","first-page":"42","volume":"57(Suppl. 8)","author":"Christenson G.A.","year":"1996","unstructured":"Christenson G.A.; Crow S.J.; The characterization and treatment of trichotillomania. J Clin Psychiatry 1996,57(Suppl. 8),42-47","journal-title":"J Clin Psychiatry"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/j.1365-4632.2006.02639.x","volume":"45","author":"Radmanesh M.","year":"2006","unstructured":"Radmanesh M.; Shafiei S.; Naderi A.H.; Isolated eyebrow and eyelash trichotillomania mimicking alopecia areata. Int J Dermatol 2006,45(5),557-560","journal-title":"Int J Dermatol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2165\/00148581-200507060-00005","volume":"7","author":"Bruce T.O.","year":"2005","unstructured":"Bruce T.O.; Barwick L.W.; Wright H.H.; Diagnosis and management of trichotillomania in children and adolescents. Paediatr Drugs 2005,7(6),365-376","journal-title":"Paediatr Drugs"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1111\/j.1365-4632.2006.02764.x","volume":"45","author":"Shelleh H.H.","year":"2006","unstructured":"Shelleh H.H.; Khan S.A.; Al-Hatiti H.S.; Trichotillomania or alopecia areata?. Int J Dermatol 2006,45(10),1196-1198","journal-title":"Int J Dermatol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"58","DOI":"10.2174\/1872213X14666200106145624","volume":"14","author":"Leung A.K.C.","year":"2020","unstructured":"Leung A.K.C.; Hon K.L.; Leong K.F.; Barankin B.; Lam J.M.; Tinea capitis: An updated review. Recent Pat Inflamm Allergy Drug Discov 2020,14(1),58-68","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"ref=102","doi-asserted-by":"crossref","first-page":"13030","DOI":"10.5070\/D32411042012","volume":"24","author":"Turra N.","year":"2018","unstructured":"Turra N.; Navarrete J.; Magliano J.; Bazzano C.; Acquired trichorrhexis nodosa: How to diagnose it? Dermatol Online J 2018,24(11),13030","journal-title":"Dermatol Online J"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"322","DOI":"10.4103\/0378-6323.174411","volume":"82","author":"Sonthalia S.","year":"2016","unstructured":"Sonthalia S.; Daulatabad D.; Azathioprine-associated anagen effluvium. Indian J Dermatol Venereol Leprol 2016,82(3),322-324","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref=104","first-page":"9434916","volume":"2018","year":"2018","unstructured":"Leung AKC, Barankin B, Leong KF. An 8-year-old child with delayed diagnosis of Netherton syndrome. Case Rep Pediatr 2018,2018,9434916","journal-title":"Case Rep Pediatr"},{"key":"ref=105","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4103\/ijt.ijt_68_18","volume":"10","author":"Zhao Y-L.","year":"2018","unstructured":"Zhao Y-L.; Zhang R-Z.; Congenital triangular alopecia: A brief report. Int J Trichology 2018,10(6),290-1","journal-title":"Int J Trichology"},{"key":"ref=106","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1590\/abd1806-4841.20165431","volume":"91","author":"Leung A.K.C.","year":"2016","unstructured":"Leung A.K.C.; Barankin B.; Incidence of congenital triangular alopecia. An Bras Dermatol 2016,91(4),556","journal-title":"An Bras Dermatol"},{"key":"ref=107","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1365-2133.2012.10955.x","volume":"166","author":"Messenger A.","year":"2012","unstructured":"Messenger A.; McKillop J.; Farrant P.; McDonagh A.; Sladden\u00e0 M.; Messenger A.; British Association of Dermatologists\u2019 guidelines for the management of alopecia areata 2012. Br J Dermatol 2012,166(5),916-26","journal-title":"Br J Dermatol"},{"key":"ref=108","first-page":"1276","volume":"136","author":"Charuwichitratana S.","year":"2000","unstructured":"Charuwichitratana S.; Wattanakrai P.; Tanrattanakorn S.; Randomized double-blind placebo-controlled trial in the treatment of alopecia areata with 0.25% desoximetasone cream. JAMA 2000,136(10),1276-7","journal-title":"JAMA"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4103\/0974-7753.82123","volume":"3","author":"Kuldeep C.","year":"2011","unstructured":"Kuldeep C.; Singhal H.; Khare A.K.; Mittal A.; Gupta L.K.; Garg A.; Randomized comparison of topical betamethasone valerate foam, intralesional triamcinolone acetonide and tacrolimus ointment in management of localized alopecia areata. Int J Trichology 2011,3(1),20-4","journal-title":"Int J Trichology"},{"key":"ref=110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jamadermatol.2013.5764","volume":"150","year":"2014","unstructured":"Lenane P, MacArthur C, Parkin PC, et al. Clobetasol propionate, 0.05%, vs. hydrocortisone, 1%, for alopecia areata in children: A randomized clinical trial. JAMA Dermatol 2014,150(1),47-50","journal-title":"JAMA Dermatol"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1001\/archderm.1963.01590150100019","volume":"87","author":"Gill K.A.","year":"1963","unstructured":"Gill K.A.; Baxter D.L.; Alopecia totalis. Treatment with fluocinolone acetonide. Arch Dermatol 1963,87,384-386","journal-title":"Arch Dermatol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0190-9622(86)70158-8","volume":"15","author":"Tosti A.","year":"1986","unstructured":"Tosti A.; De Padova M.P.; Minghetti G.; Veronesi S.; Therapies versus placebo in the treatment of patchy alopecia areata. J Am Acad Dermatol 1986,15(2 Pt 1),209-210","journal-title":"J Am Acad Dermatol"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000252466","volume":"141","author":"Pascher F.","year":"1970","unstructured":"Pascher F.; Kurtin S.; Andrade R.; Assay of 0.2 percent fluocinolone acetonide cream for alopecia areata and totalis. Efficacy and side effects including histologic study of the ensuing localized acneform response. Dermatologica 1970,141(3),193-202","journal-title":"Dermatologica"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1600-0560.1977.tb00889.x","volume":"4","author":"Montes L.F.","year":"1977","unstructured":"Montes L.F.; Topical halcinonide in alopecia areata and in alopecia totalis. J Cutan Pathol 1977,4(2),47-50","journal-title":"J Cutan Pathol"},{"key":"ref=115","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/bjd.12863","volume":"170","author":"Kassim J.M.","year":"2014","unstructured":"Kassim J.M.; Shipman A.R.; Szczecinska W.; How effective is intralesional injection of triamcinolone acetonide compared with topical treatments in inducing and maintaining hair growth in patients with alopecia areata? A Critically Appraised Topic. Br J Dermatol 2014,170(4),766-71","journal-title":"Br J Dermatol"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1080\/08035250600612298","volume":"95","author":"Hon K-L.E.L.","year":"2006","unstructured":"Hon K-L.E.L.; Kam W-Y.C.Y.; Leung T-F.F.; Lam M-C.A.C.; Wong K-Y.Y.; Lee K-C.K.C.; Luk N.M.; Fok T.F.; Ng P.C.; Steroid fears in children with eczema. Acta Paediatr 2006,95(11),1451-1455","journal-title":"Acta Paediatr"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jaad.2004.05.019","volume":"52","author":"Price V.H.","year":"2005","unstructured":"Price V.H.; Willey A.; Chen B.K.; Topical tacrolimus in alopecia areata. J Am Acad Dermatol 2005,52(1),138-139","journal-title":"J Am Acad Dermatol"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1001\/archderm.1990.01670300056006","volume":"126","author":"Fiedler V.C.","year":"1990","unstructured":"Fiedler V.C.; Wendrow A.; Szpunar G.J.; Metzler C.; DeVillez R.L.; Treatment-resistant alopecia areata. Response to combination therapy with minoxidil plus anthralin. Arch Dermatol 1990,126(6),756-759","journal-title":"Arch Dermatol"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"69S","DOI":"10.1111\/1523-1747.ep12471880","volume":"96","author":"Fiedler V.C.","year":"1991","unstructured":"Fiedler V.C.; Alopecia areata: Current therapy. J Invest Dermatol 1991,96(5),69S-70S","journal-title":"J Invest Dermatol"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/S0190-9622(87)70095-4","volume":"16","author":"Price V.H.","year":"1987","unstructured":"Price V.H.; Double-blind, placebo-controlled evaluation of topical minoxidil in extensive alopecia areata. J Am Acad Dermatol 1987,16(3 Pt 2),730-736","journal-title":"J Am Acad Dermatol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1001\/archderm.1992.01680210045005","volume":"128","author":"Olsen E.A.","year":"1992","unstructured":"Olsen E.A.; Carson S.C.; Turney E.A.; Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata. Arch Dermatol 1992,128(11),1467-1473","journal-title":"Arch Dermatol"},{"key":"ref=122","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jaad.2003.06.014","volume":"50","author":"Lucky A.W.","year":"2004","unstructured":"Lucky A.W.; Piacquadio D.J.; Ditre C.M.; A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol 2004,50(4),541-53","journal-title":"J Am Acad Dermatol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000079595","volume":"209","author":"Arca E.","year":"2004","unstructured":"Arca E.; A\u00e7ikg\u00f6z G.; Ta\u015ftan H.B.; K\u00f6se O.; Kurumlu Z.; An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia. Dermatology (Basel) 2004,209(2),117-125","journal-title":"Dermatology (Basel)"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/S0190-9622(87)80003-8","volume":"16","author":"Fiedler-Weiss V.C.","year":"1987","unstructured":"Fiedler-Weiss V.C.; Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata. J Am Acad Dermatol 1987,16(3 Pt 2),745-748","journal-title":"J Am Acad Dermatol"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000096924","volume":"214","author":"Georgala S.","year":"2007","unstructured":"Georgala S.; Befon A.; Maniatopoulou E.; Georgala C.; Topical use of minoxidil in children and systemic side effects. Dermatology (Basel) 2007,214(1),101-102","journal-title":"Dermatology (Basel)"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0733-8635(05)70400-9","volume":"14","author":"Hoffmann R.","year":"1996","unstructured":"Hoffmann R.; Happle R.; Topical immunotherapy in alopecia areata. What, how, and why?. Dermatol Clin 1996,14(4),739-744","journal-title":"Dermatol Clin"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00403-007-0759-4","volume":"299","author":"Wasy\u0142yszyn T.","year":"2007","unstructured":"Wasy\u0142yszyn T.; Koz\u0142owski W.; Zabielski S.L.; Changes in distribution pattern of CD8 lymphocytes in the scalp in alopecia areata during treatment with diphencyprone. Arch Dermatol Res 2007,299(5-6),231-7","journal-title":"Arch Dermatol Res"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S0190-9622(98)70048-9","volume":"39","author":"Rokhsar C.K.","year":"1998","unstructured":"Rokhsar C.K.; Shupack J.L.; Vafai J.J.; Washenik K.; Efficacy of topical sensitizers in the treatment of alopecia areata. J Am Acad Dermatol 1998,39(5 Pt 1),751-761","journal-title":"J Am Acad Dermatol"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/BF00416931","volume":"267","author":"Happle R.","year":"1980","unstructured":"Happle R.; Antigenic competition as a therapeutic concept for alopecia areata. Arch Dermatol Res 1980,267(1),109-114","journal-title":"Arch Dermatol Res"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1001\/jamadermatol.2018.2312","volume":"154","author":"Lee S.","year":"2018","unstructured":"Lee S.; Kim B.J.; Lee Y.B.; Lee W.S.; Hair regrowth outcomes of contact immunotherapy for patients with alopecia areata: A systematic review and meta-analysis. JAMA Dermatol 2018,154(10),1145-1151","journal-title":"JAMA Dermatol"},{"key":"ref=131","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaad.2017.07.028","volume":"78","author":"Choe S.J.","year":"2018","unstructured":"Choe S.J.; Lee S.; Lee H.; Choi J.; Lee W.S.; Efficacy of topical diphenylcyclopropenone maintenance treatment for patients with alopecia areata: A retrospective study. J Am Acad Dermatol 2018,78(1),205-207","journal-title":"J Am Acad Dermatol"},{"key":"ref=132","first-page":"1063","volume":"137","author":"Wiseman M.C.","year":"2001","unstructured":"Wiseman M.C.; Shapiro J.; MacDonald N.; Lui H.; Predictive model for immunotherapy of alopecia areata with diphencyprone. Arch Dermatol 2001,137(8),1063-1068","journal-title":"Arch Dermatol"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1365-2133.1991.tb06064.x","volume":"125","author":"Hull S.M.","year":"1991","unstructured":"Hull S.M.; Pepall L.; Cunliffe W.J.; Alopecia areata in children: Response to treatment with diphencyprone. Br J Dermatol 1991,125(2),164-168","journal-title":"Br J Dermatol"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1365-2133.1996.tb03835.x","volume":"135","author":"Schuttelaar M.L.","year":"1996","unstructured":"Schuttelaar M.L.; Hamstra J.J.; Plinck E.P.; Peereboom-Wynia J.D.; Vuzevski V.D.; Mulder P.G.; Oranje A.P.; Alopecia areata in children: Treatment with diphencyprone. Br J Dermatol 1996,135(4),581-585","journal-title":"Br J Dermatol"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0190-9622(96)90323-0","volume":"35","author":"Tosti A.","year":"1996","unstructured":"Tosti A.; Guidetti M.S.; Bardazzi F.; Misciali C.; Long-term results of topical immunotherapy in children with alopecia totalis or alopecia universalis. J Am Acad Dermatol 1996,35(2 Pt 1),199-201","journal-title":"J Am Acad Dermatol"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1365-4362.1996.tb03281.x","volume":"35","author":"Sharma V.K.","year":"1996","unstructured":"Sharma V.K.; Pulsed administration of corticosteroids in the treatment of alopecia areata. Int J Dermatol 1996,35(2),133-136","journal-title":"Int J Dermatol"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1001\/archderm.1977.01640120099035","volume":"113","author":"Fisher D.A.","year":"1977","unstructured":"Fisher D.A.; Systemic steroids for treatment of alopecia areata. Arch Dermatol 1977,113(12),1731-1732","journal-title":"Arch Dermatol"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1046\/j.1365-4362.1998.00422.x","volume":"37","author":"Alabdulkareem A.S.","year":"1998","unstructured":"Alabdulkareem A.S.; Abahussein A.A.; Okoro A.; Severe alopecia areata treated with systemic corticosteroids. Int J Dermatol 1998,37(8),622-4","journal-title":"Int J Dermatol"},{"key":"ref=139","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jaad.2004.10.873","volume":"52","author":"Kar B.R.","year":"2005","unstructured":"Kar B.R.; Handa S.; Dogra S.; Kumar B.; Placebo-controlled oral pulse prednisolone therapy in alopecia areata. J Am Acad Dermatol 2005,52(2),287-90","journal-title":"J Am Acad Dermatol"},{"key":"ref=140","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.jaad.2015.12.026","volume":"74","author":"Va\u00f1\u00f3-Galv\u00e1n S.","year":"2016","unstructured":"Va\u00f1\u00f3-Galv\u00e1n S.; Hermosa-Gelbard \u00c1.; S\u00e1nchez-Neila N.; Pulse corticosteroid therapy with oral dexamethasone for the treatment of adult alopecia totalis and universalis. J Am Acad Dermatol 2016,74(5),1005-7","journal-title":"J Am Acad Dermatol"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1046\/j.1525-1470.1998.1998015313.x","volume":"15","author":"Sharma V.K.","year":"1998","unstructured":"Sharma V.K.; Muralidhar S.; Treatment of widespread alopecia areata in young patients with monthly oral corticosteroid pulse. Pediatr Dermatol 1998,15(4),313-317","journal-title":"Pediatr Dermatol"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S0190-9622(98)70009-X","volume":"39","author":"Friedli A.","year":"1998","unstructured":"Friedli A.; Labarthe M.P.; Engelhardt E.; Feldmann R.; Salomon D.; Saurat J.H.; Pulse methylprednisolone therapy for severe alopecia areata: An open prospective study of 45 patients. J Am Acad Dermatol 1998,39(4 Pt 1),597-602","journal-title":"J Am Acad Dermatol"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000051642","volume":"202","author":"Seiter S.","year":"2001","unstructured":"Seiter S.; Ugurel S.; Tilgen W.; Reinhold U.; High-dose pulse corticosteroid therapy in the treatment of severe alopecia areata. Dermatology (Basel) 2001,202(3),230-234","journal-title":"Dermatology (Basel)"},{"key":"ref=144","first-page":"326","volume":"130","author":"Assouly P.","year":"2003","unstructured":"Assouly P.; Reygagne P.; Jouanique C.; Matard B.; Marechal E.; Reynert P.; Bachelez H.; Dubertret L.; Intravenous pulse methylprednisolone therapy for severe alopecia areata: An open study of 66 patients. Ann Dermatol Venereol 2003,130(3),326-330","journal-title":"Ann Dermatol Venereol"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S0190-9622(97)70342-6","volume":"36","author":"Shapiro J.","year":"1997","unstructured":"Shapiro J.; Lui H.; Tron V.; Ho V.; Systemic cyclosporine and low- dose prednisone in the treatment of chronic severe alopecia areata: A clinical and immunopathologic evaluation. J Am Acad Dermatol 1997,36(1),114-117","journal-title":"J Am Acad Dermatol"},{"key":"ref=146","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/09546630701846095","volume":"19","author":"Kim B.J.","year":"2008","unstructured":"Kim B.J.; Min S.U.; Park K.Y.; Combination therapy of cyclosporine and methylprednisolone on severe alopecia areata. J Dermatolog Treat 2008,19(4),216-20","journal-title":"J Dermatolog Treat"},{"key":"ref=147","first-page":"90","volume":"11","author":"Shaheedi-Dadras M.","year":"2008","unstructured":"Shaheedi-Dadras M.; Karami A.; Mollaei F.; Moravvej H.; Malekzad F.; The effect of methylprednisolone pulse-therapy plus oral cyclosporine in the treatment of alopecia totalis and universalis. Arch Iran Med 2008,11(1),90-93","journal-title":"Arch Iran Med"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"676","DOI":"10.5021\/ad.2015.27.6.676","volume":"27","author":"Yeo I.K.","year":"2015","unstructured":"Yeo I.K.; Ko E.J.; No Y.A.; Comparison of high-dose corticosteroid pulse therapy and combination therapy using oral cyclosporine with low-dose corticosteroid in severe alopecia areata. Ann Dermatol 2015,27(6),676-81","journal-title":"Ann Dermatol"},{"key":"ref=149","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jaad.2018.06.064","volume":"80","author":"Phan K.","year":"2019","unstructured":"Phan K.; Ramachandran V.; Sebaratnam D.F.; Methotrexate for alopecia areata: A systematic review and meta-analysis. J Am Acad Dermatol 2019,80(1),120-127","journal-title":"J Am Acad Dermatol"},{"key":"ref=150","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jaad.2016.09.007","volume":"76","author":"Liu L.Y.","year":"2017","unstructured":"Liu L.Y.; Craiglow B.G.; Dai F.; King B.A.; Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients. J Am Acad Dermatol 2017,76(1),22-8","journal-title":"J Am Acad Dermatol"},{"key":"ref=151","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jaad.2017.06.027","volume":"77","author":"Park H-S.","year":"2017","unstructured":"Park H-S.; Kim M-W.; Lee J.S.; Oral tofacitinib monotherapy in Korean patients with refractory moderate-to-severe alopecia areata: A case series. J Am Acad Dermatol 2017,77(5),978-80","journal-title":"J Am Acad Dermatol"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/1203475418824079","volume":"23","author":"Crowley EL","year":"2019","unstructured":"Crowley EL; Fine SC; Katipunan KK; Gooderham MJ; The use of janus kinase inhibitors in alopecia areata: A review of the literature. J Cutan Med Surg 2019,23,289-97","journal-title":"J Cutan Med Surg"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/17512433.2020.1702878","volume":"13","author":"Ismail F.F.","year":"2020","unstructured":"Ismail F.F.; Sinclair R.; JAK inhibition in the treatment of alopecia areata - a promising new dawn? 2020,13,43-51","journal-title":"JAK inhibition in the treatment of alopecia areata - a promising new dawn?"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1001\/jamadermatol.2017.0001","volume":"153","author":"Ibrahim O.","year":"2017","unstructured":"Ibrahim O.; Bayart C.B.; Hogan S.; Piliang M.; Bergfeld W.F.; Treatment of alopecia areata with tofacitinib. JAMA dermatology 2017,153(6),600-2","journal-title":"JAMA dermatology"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S0140-6736(18)32987-8","volume":"393","author":"Gilhar A.","year":"2019","unstructured":"Gilhar A.; Keren A.; Paus R.; JAK inhibitors and alopecia areata. Lancet (London, England) 2019,393(10196),318-9","journal-title":"Lancet (London, England)"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.jaad.2018.08.041","volume":"80","author":"Craiglow B.G.","year":"2019","unstructured":"Craiglow B.G.; King B.A.; Tofacitinib for the treatment of alopecia areata in preadolescent children. J Am Acad Dermatol 2019,80(2),568-570","journal-title":"J Am Acad Dermatol"},{"key":"ref=157","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jaad.2016.11.038","volume":"76","author":"Castelo-Soccio L.","year":"2017","unstructured":"Castelo-Soccio L.; Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis. J Am Acad Dermatol 2017,76(4),754-5","journal-title":"J Am Acad Dermatol"},{"key":"ref=158","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jaad.2018.08.040","volume":"80","author":"Liu L.Y.","year":"2019","unstructured":"Liu L.Y.; King B.A.; Ruxolitinib for the treatment of severe alopecia areata. J Am Acad Dermatol 2019,80(2),566-8","journal-title":"J Am Acad Dermatol"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"e89790","DOI":"10.1172\/jci.insight.89790","volume":"1","author":"Mackay-Wiggan J.","year":"2016","unstructured":"Mackay-Wiggan J.; Jabbari A.; Nguyen N.; Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata. JCI Insight 2016,1(15),e89790","journal-title":"JCI Insight"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.jdcr.2019.07.005","volume":"5","author":"Olamiju B.","year":"2019","unstructured":"Olamiju B.; Friedmann A.; King B.; Treatment of severe alopecia areata with baricitinib. JAAD Case Rep 2019,5(10),892-894","journal-title":"JAAD Case Rep"},{"key":"ref=161","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jaad.2016.01.013","volume":"74","author":"Papp K.A.","year":"2016","unstructured":"Papp K.A.; Krueger J.G.; Feldman S.R.; Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study. J Am Acad Dermatol 2016,74(5),841-50","journal-title":"J Am Acad Dermatol"},{"key":"ref=162","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3899\/jrheum.130683","volume":"41","author":"Wollenhaupt J.","year":"2014","unstructured":"Wollenhaupt J.; Silverfield J.; Safety and efficacy of tofacitinib, an oral janus kinase inhibitor, for the treatment of rheumatoid arthritis in open-lablel, longterm extension studies. J Rheumatol 2014,41(5),837-52","journal-title":"J Rheumatol"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1001\/jamadermatol.2015.4445","volume":"152","author":"Craiglow B.G.","year":"2016","unstructured":"Craiglow B.G.; Tavares D.; King B.A.; Topical ruxolitinib for the treatment of alopecia universalis. JAMA Dermatology 2016,152(4),490-1","journal-title":"JAMA Dermatology"},{"key":"ref=164","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/ijd.14192","volume":"57","author":"Bokhari L.","year":"2018","unstructured":"Bokhari L.; Sinclair R.; Treatment of alopecia universalis with topical Janus kinase inhibitors - a double blind, placebo, and active controlled pilot study. Int J Dermatol 2018,57(12),1464-70","journal-title":"Int J Dermatol"},{"key":"ref=165","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jaad.2017.10.043","volume":"78","author":"Liu L.Y.","year":"2018","unstructured":"Liu L.Y.; Craiglow B.G.; King B.A.; Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients. J Am Acad Dermatol 2018,78(2),403-404","journal-title":"J Am Acad Dermatol"},{"key":"ref=166","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jaad.2018.02.031","volume":"78","author":"Putterman E.","year":"2018","unstructured":"Putterman E.; Castelo-Soccio L.; Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis. J Am Acad Dermatol 2018,78(6),1207-1209","journal-title":"J Am Acad Dermatol"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.jaad.2005.06.031","volume":"53","author":"Ross E.K.","year":"2005","unstructured":"Ross E.K.; Bolduc C.; Lui H.; Shapiro J.; Lack of efficacy of topical latanoprost in the treatment of eyebrow alopecia areata. J Am Acad Dermatol 2005,53(6),1095-1096","journal-title":"J Am Acad Dermatol"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jaad.2008.08.029","volume":"60","author":"Roseborough I.","year":"2009","unstructured":"Roseborough I.; Lee H.; Chwalek J.; Stamper R.L.; Price V.H.; Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata. J Am Acad Dermatol 2009,60(4),705-706","journal-title":"J Am Acad Dermatol"},{"key":"ref=169","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1468-3083.2009.03543.x","volume":"24","author":"Coronel-P\u00e9rez I.M.","year":"2010","unstructured":"Coronel-P\u00e9rez I.M.; Rodr\u00edguez-Rey E.M.; Camacho-Mart\u00ednez F.M.; Latanoprost in the treatment of eyelash alopecia in alopecia areata universalis. J Eur Acad Dermatol Venereol 2010,24(4),481-5","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/bjd.12397","volume":"169","author":"Trink A.","year":"2013","unstructured":"Trink A.; Sorbellini E.; Bezzola P.; Rodella L.; Rezzani R.; Ramot Y.; Rinaldi F.; A randomized, double-blind, placebo- and active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata. Br J Dermatol 2013,169(3),690-694","journal-title":"Br J Dermatol"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/S0190-9622(85)70088-6","volume":"12","author":"Mitchell A.J.","year":"1985","unstructured":"Mitchell A.J.; Douglass M.C.; Topical photochemotherapy for alopecia areata. J Am Acad Dermatol 1985,12(4),644-649","journal-title":"J Am Acad Dermatol"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1365-2133.1993.tb03309.x","volume":"129","author":"Healy E.","year":"1993","unstructured":"Healy E.; Rogers S.; PUVA treatment for alopecia areata-does it work? A retrospective review of 102 cases. Br J Dermatol 1993,129(1),42-44","journal-title":"Br J Dermatol"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/j.1365-2133.1995.tb06925.x","volume":"133","author":"Taylor C.R.","year":"1995","unstructured":"Taylor C.R.; Hawk J.L.; PUVA treatment of alopecia areata partialis, totalis and universalis: Audit of 10 years\u2019 experience at St John\u2019s Institute of Dermatology. Br J Dermatol 1995,133(6),914-918","journal-title":"Br J Dermatol"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/j.1525-1470.2009.00980.x","volume":"26","author":"Al-Mutairi N.","year":"2009","unstructured":"Al-Mutairi N.; 308-nm excimer laser for the treatment of alopecia areata in children. Pediatr Dermatol 2009,26(5),547-550","journal-title":"Pediatr Dermatol"},{"key":"ref=175","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000381912","volume":"231","author":"Byun J.W.","year":"2015","unstructured":"Byun J.W.; Moon J.H.; Bang C.Y.; Shin J.; Choi G.S.; Effectiveness of 308-nm excimer laser therapy in treating alopecia areata, determined by examining the treated sides of selected alopecic patches. Dermatology 2015,231(1),70-6","journal-title":"Dermatology"},{"key":"ref=176","first-page":"70","volume":"231","author":"Zakaria W.","year":"2004","unstructured":"Zakaria W.; Passeron T.; Ostovari N.; Lacour J-P.; Ortonne J-P.; Effectiveness of 308-nm excimer laser therapy in treating alopecia areata, determined by examining the treated sides of selected alopecic patches. Dermatology 2004,231(1),70-6","journal-title":"Dermatology"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000051360","volume":"3","author":"Andreoli E.M.","year":"2002","unstructured":"Andreoli E.M.; Types of stress within child alopecia. Dermatology Psychosom 2002,3(1),26-29","journal-title":"Dermatology Psychosom"},{"key":"ref=178","first-page":"1362","volume":"69","author":"Peled J.U.","year":"2004","unstructured":"Peled J.U.; Psychosocial counseling may be best treatment for hair loss. Am Fam Physician 2004,69(6),1362","journal-title":"Am Fam Physician"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2147\/CCID.S22767","volume":"4","author":"Alsantali A.","year":"2011","unstructured":"Alsantali A.; Alopecia areata: A new treatment plan. Clin Cosmet Investig Dermatol 2011,4,107-115","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.1365-2133.1987.tb04937.x","volume":"117","author":"Vestey J.P.","year":"1987","unstructured":"Vestey J.P.; Savin J.A.; Natural history of severe alopecia areata. Br J Dermatol 1987,117(4),531","journal-title":"Br J Dermatol"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S1085-5629(05)80033-1","volume":"14","author":"Sahn E.E.","year":"1995","unstructured":"Sahn E.E.; Alopecia areata in childhood. Semin Dermatol 1995,14(1),9-14","journal-title":"Semin Dermatol"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1365-2230.1989.tb02604.x","volume":"14","author":"De Waard-van der Spek F.B.","year":"1989","unstructured":"De Waard-van der Spek F.B.; Oranje A.P.; De Raeymaecker D.M.; Peereboom-Wynia J.D.; Juvenile versus maturity-onset alopecia areata-a comparative retrospective clinical study. Clin Exp Dermatol 1989,14(6),429-433","journal-title":"Clin Exp Dermatol"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1071\/HE07098","volume":"18","author":"Mitchell R.","year":"2007","unstructured":"Mitchell R.; Sherker S.; Cavanagh M.; Eager D.; Falls from playground equipment: Will the new Australian playground safety standard make a difference and how will we tell? Health Promot J Austr 2007,18(2),98-104","journal-title":"Health Promot J Austr"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/S0190-9622(03)02141-8","volume":"49","author":"Tang L.","year":"2003","unstructured":"Tang L.; Lui H.; Sundberg J.P.; Bissonnette R.; McLean D.I.; Shapiro J.; Restoration of hair growth with topical diphencyprone in mouse and rat models of alopecia areata. J Am Acad Dermatol 2003,49(6),1013-1019","journal-title":"J Am Acad Dermatol"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1046\/j.1523-1747.2003.12059.x","volume":"120","author":"Tang L.","year":"2003","unstructured":"Tang L.; Cao L.; Bernardo O.; Chen Y.; Sundberg J.P.; Lui H.; Chung S.; Shapiro J.; Topical mechlorethamine restores autoimmune-arrested follicular activity in mice with an alopecia areata-like disease by targeting infiltrated lymphocytes. J Invest Dermatol 2003,120(3),400-406","journal-title":"J Invest Dermatol"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.0906-6705.2004.00098.x","volume":"13","author":"Tang L.","year":"2004","unstructured":"Tang L.; Cao L.; Sundberg J.P.; Lui H.; Shapiro J.; Restoration of hair growth in mice with an alopecia areata-like disease using topical anthralin. Exp Dermatol 2004,13(1),5-10","journal-title":"Exp Dermatol"},{"key":"ref=187","first-page":"3: 239","author":"Shapiro J.","year":"1999","unstructured":"Shapiro J.; Sundberg J.P.; Bissonnette R.; Alopecia areata-like hair loss in C3H\/HeJ mice and DEBR rats can be reversed using topical diphencyprone. J Investig Dermatology 1999,3: 239","journal-title":"J Investig Dermatology"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"2: 212-6","DOI":"10.1046\/j.1087-0024.2003.00812.x","author":"Tang L.","year":"2003","unstructured":"Tang L.; Sundberg J.P.; Lui H.; Shapiro J.; Old wine in new bottles: Reviving old therapies for alopecia areata using rodent models. J Investig Dermatology 2003,2: 212-6","journal-title":"J Investig Dermatology"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2165\/11530040-000000000-00000","volume":"11","author":"van den Biggelaar F.J.","year":"2010","unstructured":"van den Biggelaar F.J.; Smolders J.; Jansen J.F.; Complementary and alternative medicine in alopecia areata. Am J Clin Dermatol 2010,11(1),11-20","journal-title":"Am J Clin Dermatol"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1080\/00015550252948077","volume":"82","author":"Yano S.","year":"2002","unstructured":"Yano S.; Nakamura K.; Okochi H.; Tamaki K.; Analysis of the expression of cutaneous lymphocyte-associated antigen on the peripheral blood and cutaneous lymphocytes of alopecia areata patients. Acta Derm Venereol 2002,82(2),82-85","journal-title":"Acta Derm Venereol"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/ni1084","volume":"5","author":"Dillon S.R.","year":"2004","unstructured":"Dillon S.R.; Sprecher C.; Hammond A.; Bilsborough J.; Rosenfeld-Franklin M.; Presnell S.R.; Haugen H.S.; Maurer M.; Harder B.; Johnston J.; Bort S.; Mudri S.; Kuijper J.L.; Bukowski T.; Shea P.; Dong D.L.; Dasovich M.; Grant F.J.; Lockwood L.; Levin S.D.; LeCiel C.; Waggie K.; Day H.; Topouzis S.; Kramer J.; Kuestner R.; Chen Z.; Foster D.; Parrish-Novak J.; Gross J.A.; Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 2004,5(7),752-760","journal-title":"Nat Immunol"},{"key":"ref=192","author":"Siadak AW","year":"2009","unstructured":"Siadak AW; Bilsborough J; Rene S; Methods of using IL-31 monoclonal antibodies to reduce inflammation. US20090220417, 2009","journal-title":"US20090220417,"},{"key":"ref=193","author":"Siadak AW","year":"2010","unstructured":"Siadak AW; Bilsborough J; Rene S; Variable region sequences of IL-31 monoclonal antibodies and methods of use. 2010"},{"key":"ref=194","author":"Sierra M","year":"2018","unstructured":"Sierra M; Labuda T; Tanimoto A; Shinozaki Y; Treatment of alopecia areata. 2018"},{"key":"ref=195","author":"Cauwenbergh G","year":"2018","unstructured":"Cauwenbergh G; Johnson K; Methods for the treatment of alopecia areata utilizing gene modulation approaches. US20180263925, 2018","journal-title":"US20180263925,"},{"key":"ref=196","author":"Kyoto E.","year":"2018","unstructured":"Kyoto E.; Agent for the treatment of alopecia. 2018"},{"key":"ref=197","author":"Anderson DR","year":"2019","unstructured":"Anderson DR; Hockerman SL; Blinn JR; Jacobsen EJ; Pyrazolyl pyrrolo[2,3-b]pyrmidine-5-carboxylate analogs and methods of making the same. 2019"},{"key":"ref=198","author":"Christiano AM","year":"2018","unstructured":"Christiano AM; Clynes R; Methods for treating hair loss disorders. 2018"},{"key":"ref=199","author":"Simkin GO","year":"2008","unstructured":"Simkin GO; Richter AM; Hunt DWC; North JR; Lutwyche P; Boch RE; Photodynamic therapy for the treatment of hair loss. 2008"},{"key":"ref=200","author":"Lee HK","year":"2010","unstructured":"Lee HK; Alopecia healing apparatus using laser and LED. 2010"},{"key":"ref=201","author":"Jia X","year":"2005","unstructured":"Jia X; Jia J.; Compound Chinese medicinal oral preparation for treating alopecia areata and alopecia and its preparing method. 2005"},{"key":"ref=202","author":"Bruning E","year":"2010","unstructured":"Bruning E; Stone VL; Zhao R; Compositions and methods of inducing hair growth utilizing Continus coggygria. 2010"},{"key":"ref=203","author":"Millet IA","year":"2011","unstructured":"Millet IA; Dermatological pharmaceutical composition for the treatment of skin inflammation diseases, such as dermatitis, atopic dermatitis, vitiligo, alopecia areata, acne, psoriasis, pruritus or combinations of same. 2011"},{"key":"ref=204","year":"2013","unstructured":"Jacqueline ShanSandra MillerPunithavathi DURAIRAJ Use of a ginseng extract to prevent and treat alopecia areata. 2013"},{"key":"ref=205","author":"Liu Houqi","year":"2016","unstructured":"Liu Houqi; Tong M; Wang F; Wang Y; Xu C; Xu S; Xiong J; Li Q.; Hair regeneration method for mesenchymal stem cell-induced alopecia areata and application. 2016"}],"container-title":["Recent Patents on Inflammation &amp; Allergy Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/184241","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/184241\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/184241","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:32:53Z","timestamp":1696465973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/184241\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,15]]},"references-count":205,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,1,15]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1872213x14999200728145822","relation":{},"ISSN":["1872-213X"],"issn-type":[{"value":"1872-213X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,15]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-03-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}